Adefolake Oshodi
Child & Adolescent Psychiatry · Rockville, MDNPI 1326273152
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 220 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $983 and has fallen 93.2% since, to $67 in 2024. Among child & adolescent psychiatry clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 220 payments — averaging $16.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$657
- Johnson & Johnson$626
- Otsuka America Pharmaceutical, Inc.$580
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$348
- Takeda Pharmaceuticals U.S.A., Inc.$278
- Neurocrine Biosciences, Inc.$170
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,710100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 32 | $657 |
| Johnson & Johnson | 48 | $626 |
| Otsuka America Pharmaceutical, Inc. | 42 | $580 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $348 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $278 |
| Neurocrine Biosciences, Inc. | 8 | $170 |
| Eisai Inc. | 12 | $170 |
| Lundbeck LLC | 9 | $135 |
| Merck | 7 | $132 |
| Vanda Pharmaceuticals Inc. | 6 | $129 |
| AbbVie(2 entities) | 5 | $95 |
| Teva Pharmaceuticals USA, Inc. | 5 | $88 |
| Ironshore Pharmaceuticals Inc. | 3 | $64 |
| Avanir Pharmaceuticals, Inc. | 3 | $62 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Jazz Pharmaceuticals Inc. | 2 | $45 |
| Bioxcel Therapeutics, Inc. | 1 | $25 |
| Bausch Health US, LLC | 1 | $20 |
| Shire North American Group Inc | 1 | $18 |
| Adlon Therapeutics L.p. | 1 | $11 |
How this compares
$3,710 in reported general payments places this provider in the 90th percentile of 98 child & adolescent psychiatry providers in Maryland.
See all child & adolescent psychiatry providers in Maryland →
Other child & adolescent psychiatry in Rockville
- Charles GordonRockville$1K
- Antoinette StewartRockville$727
- Anna GonzagaBaltimore$180K
- Michael LabellarteTowson$92K
- Sushma JaniColumbia$11K
- Dejan BudimirovicBaltimore$10K
- Sabah HadiFrederick$7K
- Jonathan ShepherdWoodlawn$2K
- Suni JaniColumbia$2K
- Mertine JermanyEllicott City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.